Johannes Roesel

3.6k total citations · 1 hit paper
36 papers, 2.8k citations indexed

About

Johannes Roesel is a scholar working on Hematology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Johannes Roesel has authored 36 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 13 papers in Molecular Biology and 11 papers in Organic Chemistry. Recurrent topics in Johannes Roesel's work include Chronic Myeloid Leukemia Treatments (12 papers), Acute Myeloid Leukemia Research (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Johannes Roesel is often cited by papers focused on Chronic Myeloid Leukemia Treatments (12 papers), Acute Myeloid Leukemia Research (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Johannes Roesel collaborates with scholars based in Switzerland, United States and Germany. Johannes Roesel's co-authors include Sagar Lonial, Titus J. Boggon, Sumin Kang, Ting-Lei Gu, Taro Hitosugi, Jianxin Xie, Jing Chen, Georgia Z. Chen, Roberto D. Polakiewicz and Tae‐Wook Chung and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Johannes Roesel

36 papers receiving 2.7k citations

Hit Papers

Tyrosine Phosphorylation Inhibits PKM2 to Promote the War... 2009 2026 2014 2020 2009 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
    2009 618 citations Taro Hitosugi, Sumin Kang et al. Science Signaling profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johannes Roesel Switzerland 23 1.5k 750 614 419 372 36 2.8k
Herman Burger Netherlands 28 1.2k 0.8× 246 0.3× 526 0.9× 1.3k 3.0× 330 0.9× 45 2.6k
Jacques Dumas United States 22 1.7k 1.2× 435 0.6× 251 0.4× 1.1k 2.7× 564 1.5× 46 3.9k
Loredana Cleris Italy 27 1.5k 1.0× 325 0.4× 622 1.0× 543 1.3× 227 0.6× 54 2.5k
Franca Formelli Italy 42 3.8k 2.6× 683 0.9× 809 1.3× 1.3k 3.0× 354 1.0× 125 5.8k
Shundong Cang China 21 1.4k 0.9× 485 0.6× 184 0.3× 779 1.9× 679 1.8× 80 2.3k
Antonius W.M. Boersma Netherlands 21 1.3k 0.9× 820 1.1× 178 0.3× 608 1.5× 171 0.5× 28 2.0k
Volker Wacheck Austria 35 2.3k 1.6× 474 0.6× 312 0.5× 1.0k 2.4× 480 1.3× 113 3.6k
Christine Fritsch Switzerland 21 1.8k 1.2× 258 0.3× 129 0.2× 610 1.5× 401 1.1× 39 2.6k
Edoardo Marchesi Italy 19 1.1k 0.7× 285 0.4× 1.2k 1.9× 411 1.0× 117 0.3× 35 2.4k
Francesco Piazza Italy 30 1.2k 0.9× 177 0.2× 503 0.8× 732 1.7× 207 0.6× 123 2.8k

Countries citing papers authored by Johannes Roesel

Since Specialization
Citations

This map shows the geographic impact of Johannes Roesel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Roesel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Roesel more than expected).

Fields of papers citing papers by Johannes Roesel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Roesel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Roesel. The network helps show where Johannes Roesel may publish in the future.

Co-authorship network of co-authors of Johannes Roesel

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Roesel. A scholar is included among the top collaborators of Johannes Roesel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Roesel. Johannes Roesel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manley, Paul W., Giorgio Caravatti, Pascal Furet, et al.. (2018). Comparison of the Kinase Profile of Midostaurin (Rydapt) with That of Its Predominant Metabolites and the Potential Relevance of Some Newly Identified Targets to Leukemia Therapy. Biochemistry. 57(38). 5576–5590. 19 indexed citations
2.
Hitosugi, Taro, Jun Fan, Tae‐Wook Chung, et al.. (2011). Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism. Molecular Cell. 44(6). 864–877. 262 indexed citations
3.
Manley, Paul W., Sandra W. Cowan‐Jacob, Robert Cozens, et al.. (2011). Fingolimod (FTY720) Inhibits BCR-ABL Signaling Allosterically by Binding to the Myristate Binding Site. Blood. 118(21). 2746–2746. 1 indexed citations
4.
Roesel, Johannes, Pascal Furet, Guido Bold, et al.. (2010). Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison. Genes & Cancer. 1(10). 1021–1032. 33 indexed citations
5.
Hitosugi, Taro, Sumin Kang, Matthew G. Vander Heiden, et al.. (2009). Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth. Science Signaling. 2(97). ra73–ra73. 618 indexed citations breakdown →
6.
Imbach, Patricia, Marc Lang, Carlos Garcı́a-Echeverrı́a, et al.. (2006). Novel β-lactam derivatives: Potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome. Bioorganic & Medicinal Chemistry Letters. 17(2). 358–362. 17 indexed citations
7.
Roesel, Johannes, Guido Bold, Josef Brueggen, et al.. (2005). Pharmacological profile of the FLT3-Tyrosine Kinase Inhibitor AST487. Cancer Research. 65. 1409–1409. 1 indexed citations
8.
Dêbiec‐Rychter, Maria, Jan Cools, Herlinde Dumez, et al.. (2005). Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. Gastroenterology. 128(2). 270–279. 396 indexed citations
9.
Heidel, Florian H., Frank Breitenbuecher, Daniel B. Lipka, et al.. (2005). Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain. Blood. 107(1). 293–300. 211 indexed citations
10.
Furet, Pascal, Patricia Imbach, Kurt Laumen, et al.. (2004). Entry into a New Class of Potent Proteasome Inhibitors Having High Antiproliferative Activity by Structure-Based Design. Journal of Medicinal Chemistry. 47(20). 4810–4813. 51 indexed citations
11.
Eppenberger, Urs, Willy Kueng, Jean-Marc Schlaeppi, et al.. (1998). Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.. Journal of Clinical Oncology. 16(9). 3129–3136. 189 indexed citations
12.
13.
Leroux, Jean-Christophe, Robert Cozens, Johannes Roesel, et al.. (1996). pH-Sensitive Nanoparticles: An Effective Means to Improve the Oral Delivery of HIV-1 Protease Inhibitors in Dogs. Pharmaceutical Research. 13(3). 485–487. 49 indexed citations
14.
Bold, Guido, Robert Cozens, Jürgen Mestan, et al.. (1996). ChemInform Abstract: Aza‐Peptide Analogues as Potent Human Immunodeficiency Virus Type‐1 Protease Inhibitors with Oral Bioavailability.. ChemInform. 27(48). 2 indexed citations
15.
Leroux, Jean-Christophe, Robert Cozens, Johannes Roesel, et al.. (1995). Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to Mice. Journal of Pharmaceutical Sciences. 84(12). 1387–1391. 60 indexed citations
16.
Traxler, Peter, Uwe Trinks, Elisabeth Buchdunger, et al.. (1995). [(Alkylamino)methyl]acrylophenones: Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase. Journal of Medicinal Chemistry. 38(13). 2441–2448. 72 indexed citations
17.
18.
Lang, Marc & Johannes Roesel. (1993). HIV‐1 Protease Inhibitors: Development, Status, and Potential Role in the Treatment of AIDS. Archiv der Pharmazie. 326(12). 921–924. 20 indexed citations
19.
Roesel, Johannes, et al.. (1993). Cloning, expression and purification of a recombinant poly‐histidine‐linked HIV‐1 protease. FEBS Letters. 326(1-3). 275–280. 13 indexed citations
20.
Traxler, Peter, Johanna Geissler, W. G. Kump, et al.. (1991). Sulfonylbenzoyl-nitrostyrenes: Potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase. Journal of Medicinal Chemistry. 34(8). 2328–2337. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herman Burger Breakdown of academic impact, for papers by Jacques Dumas Breakdown of academic impact, for papers by Loredana Cleris Breakdown of academic impact, for papers by Franca Formelli Breakdown of academic impact, for papers by Shundong Cang Breakdown of academic impact, for papers by Antonius W.M. Boersma Breakdown of academic impact, for papers by Volker Wacheck Breakdown of academic impact, for papers by Christine Fritsch Breakdown of academic impact, for papers by Edoardo Marchesi Breakdown of academic impact, for papers by Francesco Piazza
Rankless by CCL
2026